• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MUC4在泛癌中的预后及免疫浸润综合分析:是友还是敌?

Integrative Analysis of MUC4 to Prognosis and Immune Infiltration in Pan-Cancer: Friend or Foe?

作者信息

Gao Xiao-Peng, Dong Jie-Jie, Xie Tian, Guan Xiaoqing

机构信息

Department of Gastrointestinal Surgery, Yuncheng Central Hospital, Yuncheng, China.

Department of Hepatopancreatobiliary Surgery, Yuncheng Central Hospital, Yuncheng, China.

出版信息

Front Cell Dev Biol. 2021 Jul 16;9:695544. doi: 10.3389/fcell.2021.695544. eCollection 2021.

DOI:10.3389/fcell.2021.695544
PMID:34336844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8322945/
Abstract

, a transmembrane mucin, plays important roles in epithelial renewal and differentiation. Recent studies suggest that has been implicated in pancreatic cancer pathogenesis and is expressed in various normal and cancer tissues. The underlying features of across various cancer types may allow us to ensure appropriate treatment and patient monitoring. However, the contributions of to pan-cancer have not been well characterized. In this study, we investigated the expression pattern and prognostic value of across multiple databases. We further explored genomic and epigenetic alterations of , its association with proliferation and metastasis, and the correlation with immune infiltration in different cancers. Our results characterized the distinct expression profile and prognostic values of in pan-cancer. Through examining its association with genomic alteration, tumor proliferation, and metastasis, as well as tumor infiltration, we revealed multiple function effects of . may influence prognosis, proliferation, metastasis, and immune response in opposite directions. In conclusion, our findings suggested the necessity to more carefully evaluate as a biomarker and therapeutic target and develop the new antibodies for cancer detection and intervention.

摘要

一种跨膜粘蛋白,在上皮更新和分化中发挥重要作用。最近的研究表明,其与胰腺癌发病机制有关,且在各种正常组织和癌组织中表达。其在各种癌症类型中的潜在特征可能有助于我们确保适当的治疗和患者监测。然而,其对泛癌的贡献尚未得到充分表征。在本研究中,我们在多个数据库中研究了其表达模式和预后价值。我们进一步探讨了其基因组和表观遗传改变、与增殖和转移的关联以及与不同癌症中免疫浸润的相关性。我们的结果表征了其在泛癌中的独特表达谱和预后价值。通过研究其与基因组改变、肿瘤增殖和转移以及肿瘤浸润的关联,我们揭示了其多种功能作用。其可能在相反方向上影响预后、增殖、转移和免疫反应。总之,我们的发现表明有必要更仔细地评估其作为生物标志物和治疗靶点的作用,并开发用于癌症检测和干预的新型抗体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/c735f50841ef/fcell-09-695544-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/cea176009493/fcell-09-695544-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/1e56251693c7/fcell-09-695544-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/4dbe711bc99f/fcell-09-695544-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/cfe57ccd2f25/fcell-09-695544-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/88ab74e04c66/fcell-09-695544-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/ad3856cddcf1/fcell-09-695544-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/c735f50841ef/fcell-09-695544-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/cea176009493/fcell-09-695544-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/1e56251693c7/fcell-09-695544-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/4dbe711bc99f/fcell-09-695544-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/cfe57ccd2f25/fcell-09-695544-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/88ab74e04c66/fcell-09-695544-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/ad3856cddcf1/fcell-09-695544-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4288/8322945/c735f50841ef/fcell-09-695544-g007.jpg

相似文献

1
Integrative Analysis of MUC4 to Prognosis and Immune Infiltration in Pan-Cancer: Friend or Foe?MUC4在泛癌中的预后及免疫浸润综合分析:是友还是敌?
Front Cell Dev Biol. 2021 Jul 16;9:695544. doi: 10.3389/fcell.2021.695544. eCollection 2021.
2
Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.癌症基因组图谱和癌症细胞系百科全书大规模基因组数据库的综合分析:MUC4/MUC16/MUC20 标志物与人类癌中的不良预后相关。
J Transl Med. 2018 Sep 20;16(1):259. doi: 10.1186/s12967-018-1632-2.
3
MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.黏蛋白4(MUC4)增强胰腺肿瘤细胞的增殖、存活及侵袭特性,并干扰其与细胞外基质蛋白的相互作用。
Mol Cancer Res. 2007 Apr;5(4):309-20. doi: 10.1158/1541-7786.MCR-06-0353. Epub 2007 Apr 3.
4
Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.MUC1和MUC4启动子的异常甲基化是胰腺导管腺癌潜在的预后生物标志物。
Oncotarget. 2016 Jul 5;7(27):42553-42565. doi: 10.18632/oncotarget.9924.
5
Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.靶向表皮生长因子受体(EGF受体)-信号转导和转录激活因子1(STAT1)轴可通过下调人胰腺癌中的MUC4粘蛋白来减弱肿瘤生长和转移。
Oncotarget. 2015 Mar 10;6(7):5164-81. doi: 10.18632/oncotarget.3286.
6
Clinicopathological and prognostic significance of MUC4 expression in cancers: evidence from meta-analysis.MUC4表达在癌症中的临床病理及预后意义:来自荟萃分析的证据
Int J Clin Exp Med. 2015 Jul 15;8(7):10274-83. eCollection 2015.
7
MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.MUC4黏蛋白——胰腺导管腺癌的一个治疗靶点。
Expert Opin Ther Targets. 2017 Jul;21(7):657-669. doi: 10.1080/14728222.2017.1323880. Epub 2017 May 29.
8
The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target.泛癌中USP10的预后价值及免疫浸润:一个潜在的治疗靶点
Front Oncol. 2022 Mar 31;12:829705. doi: 10.3389/fonc.2022.829705. eCollection 2022.
9
Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas.跨膜黏蛋白MUC1和MUC4在人前列腺癌中的异常表达。
Prostate. 2006 Mar 1;66(4):421-9. doi: 10.1002/pros.20372.
10
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.乳腺浸润性微乳头状癌过度表达 MUC4,并与曲妥珠单抗辅助治疗 HER2 阳性乳腺癌的不良预后相关。
BMC Cancer. 2017 Dec 28;17(1):895. doi: 10.1186/s12885-017-3897-x.

引用本文的文献

1
The multifaceted roles of mucins family in lung cancer: from prognostic biomarkers to promising targets.黏蛋白家族在肺癌中的多方面作用:从预后生物标志物到有前景的靶点。
Front Immunol. 2025 Jun 27;16:1608140. doi: 10.3389/fimmu.2025.1608140. eCollection 2025.
2
Mucins as Precision Biomarkers in Glioma: Emerging Evidence for Their Potential in Biospecimen Analysis and Outcome Prediction.黏蛋白作为胶质瘤的精准生物标志物:其在生物样本分析和预后预测中潜力的新证据
Biomedicines. 2024 Dec 11;12(12):2806. doi: 10.3390/biomedicines12122806.
3
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance.

本文引用的文献

1
Pancancer survival analysis of cancer hallmark genes.泛癌生存分析癌症标志基因。
Sci Rep. 2021 Mar 15;11(1):6047. doi: 10.1038/s41598-021-84787-5.
2
Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.黏蛋白 4 突变与肿瘤突变负担相关,并促进结肠癌患者的抗肿瘤免疫。
Aging (Albany NY). 2021 Mar 14;13(6):9043-9055. doi: 10.18632/aging.202756.
3
MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans.
结直肠癌患者来源的免疫类器官平台揭示了与免疫治疗耐药相关的癌症特异性组织标志物。
Cell Death Dis. 2024 Dec 4;15(12):878. doi: 10.1038/s41419-024-07266-5.
4
Whole-Exome Sequencing Reveals Novel Candidate Driver Mutations and Potential Druggable Mutations in Patients with High-Risk Neuroblastoma.全外显子组测序揭示高危神经母细胞瘤患者新的候选驱动突变和潜在可靶向治疗的突变
J Pers Med. 2024 Sep 8;14(9):950. doi: 10.3390/jpm14090950.
5
DNA Methylation Patterns Associated with Tinnitus in Young Adults-A Pilot Study.与青年人群耳鸣相关的 DNA 甲基化模式:一项初步研究。
J Assoc Res Otolaryngol. 2024 Oct;25(5):507-523. doi: 10.1007/s10162-024-00961-2. Epub 2024 Aug 15.
6
Genetic and dietary modulators of the inflammatory response in the gastrointestinal tract of the BXD mouse genetic reference population.BXD 遗传参考群体胃肠道炎症反应的遗传和饮食调节剂。
Elife. 2023 Oct 19;12:RP87569. doi: 10.7554/eLife.87569.
7
Cancer immune exclusion: breaking the barricade for a successful immunotherapy.癌症免疫排斥:突破壁垒以实现成功的免疫治疗。
Front Oncol. 2023 May 22;13:1135456. doi: 10.3389/fonc.2023.1135456. eCollection 2023.
8
MUC4 Expression in Oral Dysplastic Epithelium and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.MUC4在口腔发育异常上皮和口腔鳞状细胞癌中的表达:一项免疫组织化学研究。
J Int Soc Prev Community Dent. 2023 Apr 28;13(2):124-132. doi: 10.4103/jispcd.JISPCD_241_22. eCollection 2023 Mar-Apr.
9
Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer.黏蛋白作为荧光引导胰腺癌手术的对比剂靶点。
Cancer Lett. 2023 May 1;561:216150. doi: 10.1016/j.canlet.2023.216150. Epub 2023 Mar 29.
10
Mucins as Potential Biomarkers for Early Detection of Cancer.黏蛋白作为癌症早期检测的潜在生物标志物。
Cancers (Basel). 2023 Mar 7;15(6):1640. doi: 10.3390/cancers15061640.
MUC4 增强了表达癌症相关短 O-聚糖的胰腺癌细胞对吉西他滨的耐药性和恶性行为。
Cancer Lett. 2021 Apr 10;503:91-102. doi: 10.1016/j.canlet.2021.01.015. Epub 2021 Jan 22.
4
MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan-cancer.MUC4、MUC16和TTN基因的突变与预后相关,并可预测胃癌及泛癌中的肿瘤突变负荷和免疫治疗疗效。
Clin Transl Med. 2020 Aug;10(4):e155. doi: 10.1002/ctm2.155.
5
Unraveling mucin domains in cancer and metastasis: when protectors become predators.揭开癌症和转移中的黏蛋白结构域之谜:保护者如何变成掠夺者。
Cancer Metastasis Rev. 2020 Sep;39(3):647-659. doi: 10.1007/s10555-020-09896-5.
6
CVCDAP: an integrated platform for molecular and clinical analysis of cancer virtual cohorts.CVCDAP:用于癌症虚拟队列的分子和临床分析的集成平台。
Nucleic Acids Res. 2020 Jul 2;48(W1):W463-W471. doi: 10.1093/nar/gkaa423.
7
TIMER2.0 for analysis of tumor-infiltrating immune cells.TIMER2.0 用于分析肿瘤浸润免疫细胞。
Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514. doi: 10.1093/nar/gkaa407.
8
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.MUC5AC-CD44 轴在结直肠癌进展和化疗耐药中的分子意义。
Mol Cancer. 2020 Feb 25;19(1):37. doi: 10.1186/s12943-020-01156-y.
9
MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy.黏蛋白 4(MUC4)是胰腺癌免疫治疗中的一种新型肿瘤抗原。
Semin Immunol. 2020 Feb;47:101391. doi: 10.1016/j.smim.2020.101391. Epub 2020 Jan 14.
10
Core 1-derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer.核心 1 衍生的粘蛋白型 O-糖基化可预防自发性胃炎和胃癌。
J Exp Med. 2020 Jan 6;217(1). doi: 10.1084/jem.20182325.